In this summary, Robert H. Vonderheide, MD, DPhil, offers an overview of recent advances at Penn Medicine in immunological therapy for pancreatic cancer based upon antibodies that activate the patient's immune system to attack the ""scaffolding"" that supports pancreatic malignancies.
Related Links
Published
May 7, 2013
Created by
BROADCASTMED